Protease-Activated Receptor-2 Activation in Gastric Cancer Cells Promotes Epidermal Growth Factor Receptor Trans-Activation and Proliferation-Reference-Cited by-同舟云学术

Protease-Activated Receptor-2 Activation in Gastric Cancer Cells Promotes Epidermal Growth Factor Receptor Trans-Activation and Proliferation

Published:2006-07 Issue:1 Volume:169 Page:268-278
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Caruso Roberta,Pallone Francesco,Fina Daniele,Gioia Valentina,Peluso Ilaria,Caprioli Flavio,Stolfi Carmine,Perfetti Alessandra,Spagnoli Luigi Giusto,Palmieri Giampiero,MacDonald Thomas T.,Monteleone Giovanni

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Gastric cancer;Hohenberger;Lancet,2003

2. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer;Tokunaga;Cancer,1995

3. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma;Naef;Int J Cancer,1996

4. Immunohistochemical detection of cripto-1, amphiregulin and transforming growth factor alpha in human gastric carcinomas and intestinal metaplasias;Seaki;Int J Oncol,1994

5. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors;Daub;Nature,1996

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells;Journal of Cell Communication and Signaling;2023-11-22

2. Protease-activated receptors in health and disease;Physiological Reviews;2023-01-01

3. Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging;European Journal of Medicinal Chemistry;2023-01

4. Diversification of PAR signaling through receptor crosstalk;Cellular & Molecular Biology Letters;2022-09-10

5. Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR–targeted therapy response in colorectal cancer;Cancer Letters;2021-10